A Clinical Study for the Pan-vascular Interventional Robotic System
Conditions: Percutaneous Coronary Intervention; Pan-vascular Interventional Robotic System Interventions: Device: Pan-vascular interventional robotic system Sponsors: Shenzhen Aibo Medical Robot Co., LTD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2023 Category: Research Source Type: clinical trials

Safety and Efficacy of Paclitaxel Coated PTCA Balloon Catheter With a Shellac Plus Vitamin E Excipient (GENOSS ® DCB) in Patients With Coronary In-stent Restenosis (ISR): A Prospective, Multi-center, Observational Study
Conditions: Coronary Artery Disease; In-stent Restenosis Interventions: Device: Genoss ® DCB Sponsors: Seoul National University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials

Rivaroxaban Monotherapy After CYP2C19 Genotype Testing in Patients With Atrial Fibrillation and Percutaneous Coronary Intervention
Conditions: Atrial Fibrillation; Coronary Artery Disease Interventions: Drug: Rivaroxaban Sponsors: J.P.S Henriques Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials

Magenta Elevate ™ First-in-Human Clinical Study in High-Risk PCI Patients
Conditions: High-Risk Percutaneous Coronary Intervention Interventions: Device: The Elevate ™ System Sponsors: Magenta Medical Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials

Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population
Conditions: Acute Coronary Syndrome; Non ST Segment Elevation Acute Coronary Syndrome Interventions: Drug: Tafolecimab; Drug: Cholesterol Absorption Inhibitor; Drug: Statin Sponsors: China National Center for Cardiovascular Diseases; Innovent Biologics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials

Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention
Conditions: Coronary Artery Disease Interventions: Drug: Colchicine 0.5 MG Oral Tablet; Drug: Placebo Sponsors: AZ Sint-Jan AV; University Hospital, Ghent; Belgium Health Care Knowledge Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials

BPA in CTEPD Without PH
Conditions: Chronic Thromboembolic Disease Interventions: Procedure: Balloon Pulmonary Angioplasty (BPA) Sponsors: Amsterdam UMC, location VUmc; Trombosestichting Nederland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2023 Category: Research Source Type: clinical trials

Patient Centered Machine Learning Model for Bleeding and Ischemic Risk
Conditions: Coronary Artery Disease; Percutaneous Coronary Intervention Interventions: Device: Percutaneous coronary intervention Sponsors: Abbott Medical Devices; Icahn School of Medicine at Mount Sinai Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials

Effects of Cangrelor on MIcRovAscular Disfunction During Elective Percutaneous CORonary Intervention
Conditions: Coronary Artery Disease Interventions: Drug: Cangrelor 50 MG Sponsors: Federico II University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials

Evaluation of Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent
Conditions: Coronary Artery Disease; Percutaneous Coronary Intervention Interventions: Device: Genoss DES stent Sponsors: Genoss Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials

Plaque Modification And Impact On Microcirculatory Territory After Drug-Coated Balloon Percutaneous Coronary Intervention (PLAMI).
Conditions: Coronary Artery Disease; Drug Coated-balloon; Intravascular Ultrasound; Plaque Modification; Percutaneous Coronary Intervention; Microvascular Coronary Artery Disease Interventions: Device: Drug coated-balloon percutaneous coronary intervention.; Device: Angiography-derived coronary physiology (IMRangio) Sponsors: Hospital Universitario La Fe Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials

Different Doses of Colchicine on hsCRP
Conditions: Coronary Artery Disease; Percutaneous Coronary Intervention Interventions: Drug: Colchicine 0.5 MG; Drug: Colchicine 0.375 MG; Drug: Colchicine 0.25 MG; Drug: Placebo Sponsors: Wuhan Union Hospital, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials

Evaluating Efficacy and Safety of 1-year of DAPT After Genoss DES ™ Sirolimus-eluting Stent Implantation in Patients
Conditions: Coronary Artery Disease; Percutaneous Coronary Intervention; Dual Antiplatelet Therapy Interventions: Device: Genoss DES ™ stent Sponsors: Genoss Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials

Patients With Acute Coronary Syndrome (ACS) Treated With GENOSSTM Sirolimus-eluting Stent
Conditions: Acute Coronary Syndrome; Percutaneous Coronary Intervention Interventions: Device: Genoss DES Sponsors: Genoss Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials

Evaluating Efficacy and Safety of Short Duration of DAPT After Genoss DES ™ Stent Implantation in Patients
Conditions: Acute Coronary Syndrome; Percutaneous Coronary Intervention; Dual Antiplatelet Therapy Interventions: Device: Genoss DES ™ stent Sponsors: Genoss Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials